GW20070F
Anti-APOB antibody produced in chicken
affinity isolated antibody, buffered aqueous solution
Synonym(s):
Anti-Apolipoprotein B, Anti-Apolipoprotein B-100
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
biological source
chicken
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
species reactivity
human
manufacturer/tradename
Genway 15-288-20070F
technique(s)
indirect ELISA: suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... APOB(338)
Application
Anti-APOB antibody produced in chicken is suitable for indirect ELISA and western blotting analysis at a dilution of 1:500, for tissue or cell staining at a dilution of 1:200. It may also be used for serum lipid analyses and apolipoprotein assays.
Biochem/physiol Actions
Apolipoprotein B (apoB) is the main protein component of triacylglyceride (TAG)-rich lipoproteins. It includes chylomicrons as well as very low density lipoprotein (the "bad cholesterol"). The N-terminal domains of apoB support the intrinsic capability of co-translational lipid recruitment. Apolipoprotein B is considered as a key structural component of all the atherogenic lipoproteins and its genetic variation may affect plasma ApoB and lipid levels, which may influence atherogenesis.
Physical form
Solution in phosphate buffered saline containing 0.02% sodium azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine.
A A Qureshi et al.
The Journal of nutrition, 131(2), 223-230 (2001-02-13)
A tocotrienol-rich fraction (TRF(25)) and novel tocotrienols (d-P(21)-T3 and d-P(25)-T3) of rice bran significantly lowered serum and low density lipoprotein cholesterol levels in chickens. The present study evaluated the effects of novel tocotrienols on lipid metabolism in swine expressing hereditary
Jovana Nikolajevic Starcevic et al.
VASA. Zeitschrift fur Gefasskrankheiten, 43(3), 171-180 (2014-05-07)
Apolipoprotein B is a key structural component of all the atherogenic lipoproteins (LDL, VLDL and IDL). Genetic variations of the ApoB gene may affect plasma ApoB and lipid levels, thus influencing atherogenesis. The present study was designed to investigate the
Matthew A Mitsche et al.
The Journal of biological chemistry, 289(13), 9000-9012 (2014-02-12)
Apolipoprotein B (apoB) is the principal protein component of triacylglyceride (TAG)-rich lipoproteins, including chylomicrons and very low density lipoprotein, which is the precursor to LDL (the "bad cholesterol"). TAG-rich lipoprotein assembly is initiated by the N-terminal βα1 superdomain of apoB
M B Elam et al.
Arteriosclerosis, thrombosis, and vascular biology, 18(12), 1942-1947 (1998-12-16)
Cilostazol is an antiplatelet agent and vasodilator marketed in Japan for treatment of ischemic symptoms of peripheral vascular disease. It is currently being evaluated in the United States for treatment of symptomatic intermittent claudication (IC). Cilostazol has been shown to
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service